Evidence map›Paper›PMID 26546873›Full record

ArticleHuman immunology2016

HLA Haplotype Validator for quality assessments of HLA typing.

Kazutoyo Osoegawa, Steven J Mack, Julia Udell, David A Noonan, Steven Ozanne, Elizabeth Trachtenberg, Matthew Prestegaard

Abstract read
In one paragraph

Article in Human immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kazutoyo OsoegawaDepartment of Pathology, Stanford University, Stanford, CA, USA; Children's Hospital Oakland Research Institute, Oakland, CA, USA. Electronic address: kazutoyo@stanford.edu.
Steven J MackChildren's Hospital Oakland Research Institute, Oakland, CA, USA.
Julia UdellChildren's Hospital Oakland Research Institute, Oakland, CA, USA.
David A NoonanChildren's Hospital Oakland Research Institute, Oakland, CA, USA.
Steven OzanneNational Marrow Donor Program, Minneapolis, MN, USA.
Elizabeth TrachtenbergChildren's Hospital Oakland Research Institute, Oakland, CA, USA.
Matthew PrestegaardNational Marrow Donor Program, Minneapolis, MN, USA.

Funding

The Role of HLA and KIR in Rheumatoid Arthritis and Crohn's DiseaseU01AI067068 · NIAID · STANFORD UNIVERSITY · PI ERLICH, HENRY A, TRACHTENBERG, ELIZABETH A · 2005 to 2014
$10.9M
Integrated Exchange & Storage of Current and Future-Generation Immunogenomic DataR01GM109030 · NIGMS · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI HOLLENBACH, JILL ALLISON, MACK, STEVEN JOHN · 2014 to 2016
$919k
ANTIIDIOTYPIC ANTIBODIES--ENDOTOXIN RECEPTOR ANTAGONISTSF32GM019030 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI KELLOGG, TODD A · 1997 to 1999
–
NIAID NIH HHS U01 AI067068NIAID NIH HHS U01AI067068NIGMS NIH HHS F32 GM019030NIGMS NIH HHS R01 GM109030NIGMS NIH HHS R01GM19030
6 · The paper itself

Abstract

HLA alleles are observed in specific haplotypes, due to Linkage Disequilibrium (LD) between particular alleles. Haplotype frequencies for alleles in strong LD have been established for specific ethnic groups and racial categories. Application of high-resolution HLA typing using Next Generation Sequencing (NGS) is becoming a common practice in research and clinical laboratory settings. HLA typing errors using NGS occasionally occur due to allelic sequence imbalance or misalignment. Manual inspection of HLA genotypes is labor intensive and requires an in-depth knowledge of HLA alleles and haplotypes. We developed the "HLA Haplotype Validator (HLAHapV)" software, which inspects an HLA genotype for both the presence of common and well-documented alleles and observed haplotypes. The software also reports warnings when rare alleles, or alleles that do not belong to recognized haplotypes, are found. The software validates observable haplotypes in genotype data, providing increased confidence regarding the accuracy of the HLA typing, and thus reducing the effort involved in correcting potential HLA typing errors. The HLAHapV software is a powerful tool for quality control of HLA genotypes prior to the application of downstream analyses. We demonstrate the use of the HLAHapV software for identifying unusual haplotypes, which can lead to finding potential HLA typing errors.

Indexed as

HaplotypesHistocompatibility TestingSoftwareAllelesComputational BiologyDatabases, GeneticGene FrequencyHigh-Throughput Nucleotide SequencingHLA AntigensHumansLinkage DisequilibriumReproducibility of ResultsWeb BrowserHLA AntigensHaplotypeHLA-B∼C haplotype blockHLA-DRB3/4/5∼DRB1∼DQB1 haplotype blockLinkage Disequilibrium

Identifiers

PMID26546873
PMCPMC4828295

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.